Stefanie Hiltbrunner

6PUBLICATIONS
22CO-AUTHORS
Molecular targetsPredictive and prognostic markersSolid tumoursCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 24, 2023
Acquired resistance to anti-PD1 therapy in patients with NSCLC associates with immunosuppressive T cell phenotype.

Stefanie Hiltbrunner, Lena Cords, Sabrina Kasser

|Sep 22, 2022
Genomic landscape of pleural and peritoneal mesothelioma tumours.

Stefanie Hiltbrunner, Zoe Fleischmann, Ethan S Sokol

|Feb 04, 2021
CD39+PD-1+CD8+ T cells mediate metastatic dormancy in breast cancer.

Paulino Tallón de Lara, Héctor Castañón, Marijne Vermeer

|Oct 20, 2020
Cytosolic pH regulates proliferation and tumour growth by promoting expression of cyclin D1.

Lisa Maria Koch, Eivind Salmorin Birkeland, Stefania Battaglioni

Pageof 1